Literature DB >> 9515669

Prevalence of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis A viruses among Spanish adolescents.

A Gil1, A González, R Dal-Ré, P Ortega, V Dominguez.   

Abstract

The aim of this cross-sectional study was to assess the seroprevalence of antibodies against varicella zoster (VZV), herpes simplex type 1 (HSV-1) and type 2 (HSV-2), hepatitis B (HBV) and hepatitis A (HAV) viruses in adolescents (14-17 years of age) in Madrid, Spain. At the study visit, demographic data and blood samples were obtained. The enzyme linked immunosorbent assay (ELISA) method was used to assess the presence of anti-VZV, anti-HSV-1, anti-HSV-2, anti-HBc and anti-HAV antibodies. A total of 1191 serum samples were collected. Mean age (SD) and male/female ratio of the study population were 15.3 (1.1) years and 0.9, respectively. Seroprevalences obtained were as follows: anti-VZV (94%), anti-HSV-1 (46%), anti-HSV-2 (5%), anti-HBc (3%) and anti-HAV (5%). These data show that Spanish adolescents should be considered a target group for prevention programmes against HSV-2, HBV and HAV infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515669     DOI: 10.1016/s0163-4453(98)93126-7

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  9 in total

1.  Prevalence of antibodies to hepatitis A among children and adolescents in Larnaca area, Cyprus.

Authors:  A Hadjipanayis; C Hadjichristodoulou; M Kallias; K Sava; A Petsa; K Demetriadou; C Christodoulou; A Constantinou; M Sidera
Journal:  Eur J Epidemiol       Date:  1999-11       Impact factor: 8.082

Review 2.  Genital herpes simplex virus infection in the adolescent: special considerations for management.

Authors:  Lawrence R Stanberry; Susan L Rosenthal
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 3.  Recent trends in the epidemiology of sexually transmitted infections in the European Union.

Authors:  K A Fenton; C M Lowndes
Journal:  Sex Transm Infect       Date:  2004-08       Impact factor: 3.519

4.  Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies.

Authors:  H H Feucht; M Schröter; B Zöllner; S Polywka; R Laufs
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo.

Authors:  Reena H Doshi; Vivian H Alfonso; Patrick Mukadi; Nicole A Hoff; Sue Gerber; Ado Bwaka; Stephen G Higgins; Cyrus Sinai; Brian Cowell; Guillaume Ngoie Mwamba; Emile Okitolonda; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  Pediatr Infect Dis J       Date:  2018-02       Impact factor: 2.129

6.  Varicella susceptibility in a Canadian population.

Authors:  S Ratnam
Journal:  Can J Infect Dis       Date:  2000-09

7.  Risk factors of herpes simplex type 1 (HSV-1) infection and lifestyle factors associated with HSV-1 manifestations.

Authors:  C Stock; F Guillén-Grima; J H de Mendoza; B Marin-Fernandez; I Aguinaga-Ontoso; A Krämer
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

8.  Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain).

Authors:  Lluís Salleras; Angela Domínguez; Pere Plans; Josep Costa; Neus Cardeñosa; Núria Torner; Antoni Plasència
Journal:  Med Microbiol Immunol       Date:  2007-11-15       Impact factor: 4.148

9.  Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Authors:  Margarita Riera-Montes; Kaatje Bollaerts; Ulrich Heininger; Niel Hens; Giovanni Gabutti; Angel Gil; Bayad Nozad; Grazina Mirinaviciute; Elmira Flem; Audrey Souverain; Thomas Verstraeten; Susanne Hartwig
Journal:  BMC Infect Dis       Date:  2017-05-18       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.